Jeff Walsh Email & Phone Number
@aya.yale.edu
7 phones found area 978, 339, and 617
LinkedIn matched
Who is Jeff Walsh? Overview
A concise factual answer block for searchers comparing this professional profile.
Jeff Walsh is listed as Biotech Executive and Board Member with 30+ years of company building experience. at nChroma Bio, based in Wellesley Hills, Massachusetts, United States. AeroLeads shows a work email signal at aya.yale.edu, phone signal with area code 978, 339, 617, and a matched LinkedIn profile for Jeff Walsh.
Jeff Walsh previously worked as Chief Executive Officer at Nchroma Bio and Executive Teaching Fellow at Questrom School Of Business, Boston University. Jeff Walsh holds Mba, Health Care, Finance from Northwestern University - Kellogg School Of Management.
Email format at nChroma Bio
This section adds company-level context without repeating Jeff Walsh's masked contact details.
AeroLeads found 1 current-domain work email signal for Jeff Walsh. Compare company email patterns before reaching out.
About Jeff Walsh
More than 30 years of experience with high growth, public and private life sciences companies including Chief Financial Officer, Chief Operating Officer & Chief Strategy Officer roles with responsibility for strategy, finance, business development, program leadership, commercial development, operations and legal functions.- Joined Third Rock Ventures in 2022 as a Venture Partner with the hope of helping to build some of the next great healthcare breakthrough companies.- Joined bluebird in 2011 with broad operations, business development, commercial development, program management, strategy and global finance responsibilities. As COO/CFO, helped drive the company's overall growth from a 20 person start-up to a global 1,200+ employee research, development and commercial enterprise over 9 years. Developed and was responsible for bluebird's severe genetic disease franchise and oncology franchise strategies as well as the overall corporate development strategy including the foundational deal with Celgene/BMS which led to the discovery of Ide-cell (Abecma). Led BLUE's initial public offering in 2013 and subsequent equity financings, totaling over $3 billion. - Active member of the Board of Directors of several biotech companies: Tevard Biosciences and Tenaya Therapeutics (TNYA - Audit Chair and Comp Committee).- Former member of the Board of Directors (Executive Committee Member and Treasurer) of ARM (the Alliance for Regenerative Medicine). - Former chief business officer of Taligen Therapeutics leading the financial management, commercial development and business development of the company. Played a key role in the growth of the company as well as the sale of Taligen to Alexion Pharmaceuticals in January 2011.- Previously held senior level business development, finance, strategic planning and operations roles at Allscripts (MDRX), PathoGenesis (PGNS sold to Chiron for $700 million), EXACT Sciences (EXAS) and Inotek Pharmaceuticals.- Started career at SmithKline Beecham in finance, worldwide business development and managed care contracting roles.- Received M.B.A. from the Kellogg Graduate School of Management at Northwestern University and B.A. from Yale University.Specialties: Strategy, Financial Management, M&A, Business Development, Legal, Business Operations, Fund Raising, Commercial Development & Culture Building
Listed skills include Biotechnology, Strategy, Business Development, Mergers And Acquisitions, and 25 others.
Jeff Walsh's current company
Company context helps verify the profile and gives searchers a useful next step.
Jeff Walsh work experience
A career timeline built from the work history available for this profile.
Executive Teaching Fellow
Current
Board Member, Chair Of The Audit Committee, Compensation Committee
CurrentTenaya is a company with a mission to discover, develop and deliver curative therapies that target the underlying causes of heart disease. Tenaya was founded by world leading scientists and seeks to address heart disease through three distinct and multi-modality platforms: a Regeneration Platform; a Gene Therapy Platform and a Precision Medicine Platform.
Board Member
CurrentAmazing new company dedicated to finding a cure for rare genetic diseases with an initial focus on genetic forms of epilepsy including Dravet Syndrome. I am privileged to work with such an amazing team of dedicated parents, passionate leaders and world-renowned scientists.
Chief Executive Officer
Nvelop Therapeutics was founded in 2022 to address the challenge of efficiently delivering therapeutic cargoes to target cells in vivo. Nvelop’s next-generation platforms enable highly efficient and cell-specific in vivo delivery of a wide range of cargoes to many types of target cells. The two platforms were independently developed in the labs of.
Venture Partner
Strategic Advisor
Chief Financial And Strategy Officer
Bluebird bio is a commercial stage biotechnology company leading the way in next generation gene therapy technologies and products for the treatment of severe genetic diseases and oncology. Bluebird's novel and proprietary approach has the potential to radically transform the way rare genetic diseases and cancer are treated and managed.
Board Member, Executive Committee Member, Treasurer
Chief Business Officer
Taligen was acquired by Alexion for up to $478 million including $111 million in upfront cash in 2011. As CBO of Taligen, responsible for financial management, business development, strategy, legal and general business operations for this protein therapeutics and antibody biotechnology firm.
Chief Business Officer
Member of Inotek’s Executive Management Team with responsibility for business development, financial and corporate planning, strategic product development, and legal.
Vp Business Development And Strategy
Sr. Director, Coporate Finance & Planning
Acquired by Chiron in 2000 for $700 million.
Director/Vp, Managed Care
Sr. Manager, Worldwide Business Development
Jeff Walsh education
Mba, Health Care, Finance
Ba, Sociology, Economics
Frequently asked questions about Jeff Walsh
Quick answers generated from the profile data available on this page.
What company does Jeff Walsh work for?
Jeff Walsh works for nChroma Bio.
What is Jeff Walsh's role at nChroma Bio?
Jeff Walsh is listed as Biotech Executive and Board Member with 30+ years of company building experience. at nChroma Bio.
What is Jeff Walsh's email address?
AeroLeads has found 1 work email signal at @aya.yale.edu for Jeff Walsh at nChroma Bio.
What is Jeff Walsh's phone number?
AeroLeads has found 7 phone signal(s) with area code 978, 339, 617 for Jeff Walsh at nChroma Bio.
Where is Jeff Walsh based?
Jeff Walsh is based in Wellesley Hills, Massachusetts, United States while working with nChroma Bio.
What companies has Jeff Walsh worked for?
Jeff Walsh has worked for Nchroma Bio, Questrom School Of Business, Boston University, Tenaya Therapeutics, Tevard Biosciences, and Nvelop Therapeutics.
How can I contact Jeff Walsh?
You can use AeroLeads to view verified contact signals for Jeff Walsh at nChroma Bio, including work email, phone, and LinkedIn data when available.
What schools did Jeff Walsh attend?
Jeff Walsh holds Mba, Health Care, Finance from Northwestern University - Kellogg School Of Management.
What skills is Jeff Walsh known for?
Jeff Walsh is listed with skills including Biotechnology, Strategy, Business Development, Mergers And Acquisitions, Life Sciences, Strategic Planning, Finance, and Executive Management.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial